Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Michel Stoffel"'
Autor:
Michel Stoffel, Norella C T Kong, F. Calbo-Torrecillas, S. A. Kee, Bernard Hoet, J. L. Miguel, Jiri Beran, Anna Vilella, E. Lopez De Novales, C. Sanchez, J.-M. Bayas, Karthik Srinivasa
Publikováno v:
Kidney International. 73:856-862
Prehemodialysis and hemodialysis patients are at an increased risk of hepatitis B infection and have an impaired immune response to hepatitis B vaccines. We evaluated the immune response to the new adjuvant of hepatitis B vaccine AS04 (HBV-AS04) in t
Autor:
Javier Díez-Domingo, D Van Esso, Don Roberton, Michel Stoffel, Helen Marshall, J Verdaguer, C-E Flodmark, Ilse Dieussaert, J Marés, G Lewald, Lars Rombo, J de la Flor, Etienne Sokal, Terry Nolan, J.M. Casanovas
Publikováno v:
Vaccine
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
This study was conducted to compare the reactogenicity, immunogenicity and safety of a combined two-dose (0, 6 months) hepatitis A and B vaccine (720 EL U HAV, 20 mcg HBsAg) with the established three-dose (0, 1 and 6 months) hepatitis A and B vaccin
Autor:
Sirli Meriste, Françoise Collard, Nadia Tornieporth, I. Lutsar, Michel Stoffel, V. Bakasenas, Vytautas Usonis
Publikováno v:
Vaccine. 23:2602-2606
Two studies were undertaken to investigate the concomitant administration of combined hepatitis A/B vaccine with a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with Haemophilus influenzae vaccine (DTPa-IPV/Hib), or w
Autor:
Geert Leroux-Roels, Isabelle Desombere, Michel Stoffel, Pierre Van Damme, Marie Van der Wielen, Norbert De Clercq, Christian Goilav
Publikováno v:
Vaccine
About 510% of the general adult population respond inadequately to hepatitis B vaccination. The histocompatibility leucocyte antigen (HLA) DQ2, DR3 and DR7 phenotypes have been linked with non-responsiveness to hepatitis B vaccination. A first part o
Publikováno v:
Scandinavian Journal of Infectious Diseases. 34:610-614
An open-label randomized study was undertaken to compare a 2-dose regimen (Months 0 and 6) of hepatitis B surface antigen (HBsAg) vaccine formulated with a novel adjuvant (HBsAg/AS04) with a standard 3-dose regimen (Months 0, 1 and 6) of licensed rec
Publikováno v:
Journal of Vaccines & Vaccination.
This opinion paper describes the experience of GSK Bio in developing two vaccines with a novel Adjuvant System (AS04) against two viral infections, Human papillomavirus (HPV) and Hepatitis B virus (HBV). Developing a vaccine against HPV is difficult
Autor:
Olga Selnikova, Leon Heron, Pierre Van Damme, Anna Moiseieva, Marie Van der Wielen, Karin Levie, Michel Stoffel, Bernard Hoet
Publikováno v:
Vaccine
This trial assessed the immunogenicity, safety and reactogenicity of a two-dose hepatitis B immunisation regimen (thiomersal-free Engerix-B 20 microg HBsAg doses 6 months apart) compared to the standard three-dose vaccination regimen (preservative-fr
Autor:
Birgit Kallinowski, Michel Stoffel, Jean-Pierre Zarski, Frederik Nevens, J.-M. Bayas, Christophe Duvoux, F. Pons, Claire Vanlemmens, Jane N. Zuckerman, Peter Neuhaus, Andrew K. Burroughs, Maria Buti, Faouzi Saliba, Maria-Christina Jung, Enrique Fraga Rivas, Virginie Hamtiaux
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 12(10)
Patients with chronic liver disease are at higher risk of hepatitis B (HB) virus infection before and after liver transplantation, and they commonly have e. suboptimal immune response to HB vaccines. In this randomized trial, we compared the immunoge
Publikováno v:
Vaccine. 25(8)
Response to hepatitis A and B vaccines has been reported to decline with age. This open, prospective, single-site study examined the long-term response to the combined hepatitis A/B vaccine Twinrix in 98 primary responders aged 45-67 years. Levels of
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 11(10)
Strategies using lamivudine and hepatitis B immunoglobulins (HBIg) for prevention of hepatitis B virus (HBV) reinfection after liver transplantation (LT) are expensive since life-long treatment is needed. We evaluated the possibility to obtain protec